Skip to main content

Advertisement

Log in

Chronological effects of non-steroidal anti-inflammatory drug therapy on oxidative stress and antioxidant status in patients with rheumatoid arthritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Introduction/Objectives

Non-steroidal anti-inflammatory drugs (NSAIDs) are effective in reducing pain and inflammation in rheumatoid arthritis and other joint- and muscle-associated diseases. However, the extensive, long-term, and over the counter administration of NSAIDs may cause various side effects in the patients. In the present study, the chronological effect of NSAIDs on oxidative stress and antioxidant status in patients with rheumatoid arthritis was studied.

Methods

The study included 100 female individuals categorized in four major groups: (1) control group consisting of age- and gender-matched healthy individuals, (2) NRA-NSAID individuals taking NSAIDs without any history of RA, (3) RA individuals with a history of RA but not taking NSAIDs, and (4) RA-NSAID individuals with chronic RA and taking NSAIDs for a long period. The sera of the participants were analyzed for the oxidative stress and antioxidant status.

Results

The RA-NSAID group showed the significantly highest oxidative stress, in terms of malondialdehyde content and lipid-reducing ability as determined in thiocyanate and hemoglobin-induced linoleic acid systems. However, the free radical scavenging ability of the RA-NSAID group, against 2,2-diphenyl-1-picrylhydrazyl, hydroxyl, superoxide, and 2,2-azino-bis-tetrazolium sulfate radicals, was found to be lower than those of the other study groups. The regression analysis of the experimental data showed a significant positive relationship between duration of NSAID intake and malondialdehyde production, lipid-reducing ability, and metal chelating ability in the RA-NSAID patients. The free radical scavenging abilities of the RA-NSAID group were negatively correlated with the duration of NSAID intake.

Conclusions

The prolonged use of NSAIDs significantly increased the oxidative stress and decrease the antioxidant potential of both the RA patients and NRA individuals. The study provides awareness to the public particularly the RA patients regarding the risk of oxidative stress–associated abnormalities caused by the frequent and prolonged use of NSAIDs for temporary relief from pain.

Key Points

The study presents the effects of long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) on antioxidant status of patients with rheumatoid arthritis.

The continuous administration of NSAIDs has been found to significantly increase the oxidative stress of the patients with rheumatoid arthritis as well as the individuals with no signs of rheumatoid arthritis.

The prolonged NSAID therapy also decreased the antioxidant potential of the patients with rheumatoid arthritis as well as the individuals with no signs of rheumatoid arthritis.

The study would be a significant and valuable contribution to the literature for the awareness regarding the use of NSAIDs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

All data generated or analyzed during this study are included in this article.

References

  1. McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205–2219

    CAS  PubMed  Google Scholar 

  2. Purabdollah M, Lakdizaji S, Rahmani A, Hajalilu M, Ansarin K (2015) Relationship between sleep disorders, pain and quality of life in patients with rheumatoid arthritis. J Caring Sci 4:233–241

    PubMed  PubMed Central  Google Scholar 

  3. Bala A, Mondal C, Haldar PK, Khandelwal B (2017) Oxidative stress in inflammatory cells of patient with rheumatoid arthritis: clinical efficacy of dietary antioxidants. Inflammopharmacology 25:595–607

    CAS  PubMed  Google Scholar 

  4. Pretorius E, Akeredolu O-O, Soma P, Kell DB (2017) Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability. Exp Biol Med 242:355–373

    CAS  Google Scholar 

  5. Turesson C, Bergström U, Pikwer M, Nilsson JÅ, Jacobsson LTH (2015) High serum cholesterol predicts rheumatoid arthritis in women, but not in men: a prospective study. Arthritis Res Ther 17:284

    PubMed  PubMed Central  Google Scholar 

  6. Sparks JA, Chang S-C, Liao KP, Lu B, Fine AR, Solomon DH, Costenbader KH, Karlson EW (2016) Rheumatoid arthritis and mortality among women during 36 years of prospective follow-up: results from the nurses’ health study. Arthritis Care Res 68:753–762

    Google Scholar 

  7. Turesson C, O’fallon WM, Crowson CS et al (2003) Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 62:722–727

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Turesson C, Jacobsson LTH (2004) Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 33:65–73

    CAS  PubMed  Google Scholar 

  9. Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundström C, Klareskog L (2006) Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 54:692–701

    PubMed  Google Scholar 

  10. Franklin J, Lunt M, Bunn D, Symmons D, Silman A (2007) Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis. Ann Rheum Dis 66:308–312

    PubMed  Google Scholar 

  11. Turesson C (2013) Extra-articular rheumatoid arthritis. Curr Opin Rheumatol 25:360–366

    CAS  PubMed  Google Scholar 

  12. Birnbaum J (2015) Facial weakness, otalgia, and hemifacial spasm: a novel neurological syndrome in a case-series of 3 patients with rheumatic disease. Medicine 94:e1445

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Kundu S, Ghosh P, Datta S, Ghosh A, Chattopadhyay S, Chatterjee M (2012) Oxidative stress as a potential biomarker for determining disease activity in patients with rheumatoid arthritis. Free Radic Res 46:1482–1489

    CAS  PubMed  Google Scholar 

  14. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Care Res 59:1690–1697

    Google Scholar 

  15. Gupta A, Fomberstein B (2009) Evaluating cardiovascular risk in rheumatoid arthritis. Lupus 26

  16. Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D (2012) Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 71:1524–1529

    PubMed  Google Scholar 

  17. Jazayeri S, Hoshyarrad A, Hoseini F, Fasihi-Radmandi M (2010) Effects of antioxidant supplementations on oxidative stress in rheumatoid arthritis patients. J Biol Sci 10:63–66

    Google Scholar 

  18. Bala A, Haldar PK (2013) Free radical biology in cellular inflammation related to rheumatoid arthritis. OA Arthritis 1:15

    Google Scholar 

  19. Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME, Cochrane Musculoskeletal Group (2014) Methotrexate for treating rheumatoid arthritis. Cochrane Database Syst Rev

  20. Singh JA, Wells GA, Christensen R, Tanjong Ghogomu E, Maxwell LJ, MacDonald JK, Filippini G, Skoetz N, Francis DK, Lopes LC, Guyatt GH, Schmitt J, la Mantia L, Weberschock T, Roos JF, Siebert H, Hershan S, Cameron C, Lunn MPT, Tugwell P, Buchbinder R, Cochrane Musculoskeletal Group (2011) Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev

  21. Eyichukwu GO (2010) Non-steroidal anti inflammatory drugs usage in orthopaedics and trauma practice—a guide and review. Niger J Med 19:374–381

    CAS  PubMed  Google Scholar 

  22. Ghosh R, Alajbegovic A, Gomes AV (2015) NSAIDs and cardiovascular diseases: role of reactive oxygen species. Oxidative Med Cell Longev 2015:1–25

    Google Scholar 

  23. Arachchillage DRJ, Makris M (2016) Choosing and using non-steroidal anti-inflammatory drugs in haemophilia. Haemophilia 22:179–187

    CAS  PubMed  Google Scholar 

  24. Rostom A, Dube C, Wells GA et al (2002) Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev

  25. Lin J, Zhang W, Jones A, Doherty M (2004) Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 329:324

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Aithal GP, Day CP (2007) Nonsteroidal anti-inflammatory drug–induced hepatotoxicity. Clin Liver Dis 11:563–575

    PubMed  Google Scholar 

  27. Lee A, Cooper MG, Craig JC et al (2007) Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function. Cochrane Database Syst Rev

  28. Mateos JL (2010) Selective inhibitors of cyclooxygenase-2 (COX-2), celecoxib and parecoxib: a systematic review. Drugs Today (Barcelona, Spain: 1998) 46:1–25

    Google Scholar 

  29. Syed M, Skonberg C, Hansen SH (2016) Inhibition of ATP synthesis by fenbufen and its conjugated metabolites in rat liver mitochondria. Toxicol in Vitro 31:23–29

    CAS  PubMed  Google Scholar 

  30. Ozkan Y, Yardỳm-Akaydỳn S, Sepici A et al (2007) Oxidative status in rheumatoid arthritis. Clin Rheumatol 26:64–68

    PubMed  Google Scholar 

  31. Sarban S, Kocyigit A, Yazar M, Isikan UE (2005) Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 38:981–986

    CAS  PubMed  Google Scholar 

  32. Chandankhede MS, Gupta MM (2013) Oxidative stress and antioxidant status in patients with rheumatoid arthritis. Int J Biol Med Res 4:3088–3090

    Google Scholar 

  33. Mateen S, Moin S, Khan AQ, Zafar A, Fatima N (2016) Increased reactive oxygen species formation and oxidative stress in rheumatoid arthritis. PLoS One 11:e0152925

    PubMed  PubMed Central  Google Scholar 

  34. Quiñonez-Flores CM, González-Chávez SA, Del Río ND (2016) Pacheco-Tena C (2016) oxidative stress relevance in the pathogenesis of the rheumatoid arthritis: a systematic review. Biomed Res Int 2016:1–14

    Google Scholar 

  35. Kardeş S, Karagülle M, Durak İ, Avcı A, Karagülle MZ (2018) Association of oxidative stress with clinical characteristics in patients with rheumatoid arthritis. Eur J Clin Investig 48:e12858

    Google Scholar 

  36. Weitner T, Inić S, Jablan J, Gabričević M, Domijan AM (2016) Spectrophotometric determination of malondialdehyde in urine suitable for epidemiological studies. Croat Chem Acta 89:133–139

    CAS  Google Scholar 

  37. Sánchez-Moreno C, Larrauri JA, Saura-Calixto F (1998) A procedure to measure the antiradical efficiency of polyphenols. J Sci Food Agric 76:270–276

    Google Scholar 

  38. Shad MA, Pervez H, Zafar ZI et al (2012) Physicochemical properties, fatty acid profile and antioxidant activity of peanut oil. Pak J Bot 44:435–440

    CAS  Google Scholar 

  39. Smirnoff N, Cumbes QJ (1989) Hydroxyl radical scavenging activity of compatible solutes. Phytochemistry 28:1057–1060

    CAS  Google Scholar 

  40. Li X (2012) Improved pyrogallol autoxidation method: a reliable and cheap superoxide-scavenging assay suitable for all antioxidants. J Agric Food Chem 60:6418–6424

    CAS  PubMed  Google Scholar 

  41. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26:1231–1237

    CAS  PubMed  Google Scholar 

  42. Nawaz H, Shad MA, Rehman T, Ramzan A (2016) Influence of high-dose gamma radiation and particle size on antioxidant properties of maize (Zea mays L.) flour. Braz J Pharm Sci 52:771–780

    CAS  Google Scholar 

  43. Bae S-H, Suh H-J (2007) Antioxidant activities of five different mulberry cultivars in Korea. LWT-Food Sci Technol 40:955–962

    CAS  Google Scholar 

  44. Berker KI, Güçlü K, Demirata B, Apak R (2010) A novel antioxidant assay of ferric reducing capacity measurement using ferrozine as the colour forming complexation reagent. Anal Methods 2:1770–1778

    CAS  Google Scholar 

  45. Nozaki Y, Kusuhara H, Kondo T, Iwaki M, Shiroyanagi Y, Nakayama H, Horita S, Nakazawa H, Okano T, Sugiyama Y (2007) Species difference in the inhibitory effect of nonsteroidal anti-inflammatory drugs on the uptake of methotrexate by human kidney slices. J Pharmacol Exp Ther 322:1162–1170

    CAS  PubMed  Google Scholar 

  46. Lally F, Smith E, Filer A, Stone MA, Shaw JS, Nash GB, Buckley CD, Ed Rainger G (2005) A novel mechanism of neutrophil recruitment in a coculture model of the rheumatoid synovium. Arthritis Rheum 52:3460–3469

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Kunsch C, Sikorski JA, Sundell CL (2005) Oxidative stress and the use of antioxidants for the treatment of rheumatoid arthritis. Curr Med Chem Immunol Endocr Metab Agents 5:249–258

    CAS  Google Scholar 

  48. Galati G, Tafazoli S, Sabzevari O, Chan TS, O’Brien PJ (2002) Idiosyncratic NSAID drug induced oxidative stress. Chem Biol Interact 142:25–41

    CAS  PubMed  Google Scholar 

  49. Esterbauer H, Cheeseman KH (1990) [42] Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. In: Methods in enzymology. Elsevier, pp 407–421

  50. Ayala A, Muñoz MF, Argüelles S (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Med Cell Longev 2014:1–31

    CAS  Google Scholar 

  51. Karatas F, Ozates I, Canatan H, Halifeoglu I, Karatepe M, Colakt R (2003) Antioxidant status & lipid peroxidation in patients with rheumatoid arthritis. Indian J Med Res 118:178–181

    CAS  PubMed  Google Scholar 

  52. Goldfarb AH, Patrick SW, Bryer S, You T (2005) Vitamin C supplementation affects oxidative-stress blood markers in response to a 30-minute run at 75% VO2max. Int J Sport Nutr Exerc Metab 15:279–290

    CAS  PubMed  Google Scholar 

  53. Saxton JM, Donnelly AE, Roper HP (1994) Indices of free-radical-mediated damage following maximum voluntary eccentric and concentric muscular work. Eur J Appl Physiol Occup Physiol 68:189–193

    CAS  PubMed  Google Scholar 

  54. Nimse SB, Pal D (2015) Free radicals, natural antioxidants, and their reaction mechanisms. RSC Adv 5:27986–28006. https://doi.org/10.1039/C4RA13315C

    Article  CAS  Google Scholar 

  55. Niki E (2001) Lipid peroxidation and its inhibition: overview and perspectives. J Oleo Sci 50:313–320

    CAS  Google Scholar 

  56. Ashton T, Young IS, Davison GW, Rowlands CC, McEneny J, van Blerk C, Jones E, Peters JR, Jackson SK (2003) Exercise-induced endotoxemia: the effect of ascorbic acid supplementation. Free Radic Biol Med 35:284–291

    CAS  PubMed  Google Scholar 

  57. McAnulty S, McAnulty L, Nieman D, Morrow J, Dumke C, Henson D (2007) Effect of NSAID on muscle injury and oxidative stress. Int J Sports Med 28:909–915

    CAS  PubMed  Google Scholar 

  58. Flora SJS, Mittal M, Mehta A (2008) Heavy metal induced oxidative stress & its possible reversal by chelation therapy. Indian J Med Res 128:501

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are grateful to the Department of Biochemistry, Bahauddin Zakariya University for providing the basic facilities to conduct this research study.

Code availability

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

Haq Nawaz contributed to the study design, supervised the entire research project from hypothesis to completion, and takes responsibility for the integrity and accuracy of the data. Asma Ali contributed to designing the project, sample collection, and experimental work in the laboratory. Tanzila Rehman and Amna Aslam contributed to the data analysis and write up of the manuscript.

Corresponding author

Correspondence to Haq Nawaz.

Ethics declarations

Disclosures

None.

Ethics approval and consent to participate

The study was approved by the Board of Advanced Studies and Research and Departmental Ethical Committee and conducted at the Department of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan, and the written informed consent was obtained from all participants.

Consent for publication

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nawaz, H., Ali, A., Rehman, T. et al. Chronological effects of non-steroidal anti-inflammatory drug therapy on oxidative stress and antioxidant status in patients with rheumatoid arthritis. Clin Rheumatol 40, 1767–1778 (2021). https://doi.org/10.1007/s10067-020-05438-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-020-05438-0

Keywords

Navigation